Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32101| Title: | Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers? | Austin Authors: | Klein, Oliver ;Kee, Damien ;Nagrial, Adnan;Markman, Ben;Underhill, Craig;Michael, Michael;Behren, Andreas;Palmer, Jodie ;Tebbutt, Niall C ;Carlino, Matteo S;Cebon, Jonathan S | Affiliation: | Medical Oncology Blacktown Hospital, Blacktown, New South Wales, Australia. Department of Medical Oncology, Alfred Health, Prahran, Victoria, Australia. Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, New South Wales, Australia. Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Olivia Newton-John Cancer Research Institute Blacktown Hospital, Blacktown, New South Wales, Australia. |
Issue Date: | 1-Apr-2023 | Date: | 2023 | Publication information: | Cancer 2023-04-01; 129(7) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32101 | DOI: | 10.1002/cncr.34660 | ORCID: | 0000-0003-0022-9553 |
Journal: | Cancer | Start page: | 1129 | End page: | 1130 | PubMed URL: | 36692958 | ISSN: | 1097-0142 | Type: | Journal Article | Subjects: | Antibodies, Monoclonal/therapeutic use |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.